Publication | Closed Access

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

Metastatic Breast CancerBreast OncologyMedicineBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation Oncology